Influence of realistic airflow rate on aerosol generation by nebulizers

International Journal of Pharmaceutics

Volumn 371, Issue 1-2, 2009, Pages 99-105

  Vecellio, Laurent ^a   Kippax, Paul ^b   Rouquette, Stephane ^c   Diot, Patrice ^a,d,e  

^a UNIVERSITÉ DE TOURS   (France)

^b MALVERN INSTRUMENTS LTD   (United Kingdom)

^c Malvern Instrument SA   (France)

^d INSERM   (France)

^e IFR 135   (France)

Author keywords

Aerosol; Concentration; Laser; Nebulizer; Size

Indexed keywords

AEROSOL; AIRFLOW; ARTICLE; BREATHING; CONCENTRATION (PARAMETERS); INHALATION; LASER DIFFRACTION; MATHEMATICAL MODEL; MEASUREMENT; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG DELIVERY SYSTEMS; MODELS, THEORETICAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 62749107067     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.12.027     Document Type: Article

References (21)

1. Asgharian B., Hofmann W., and Bergmann R. Particle deposition in a multiple-path model of the human lung. Aerosol. Sci. Technol. 34 (2001) 332-339
2. Bennett W.D., Scheuch G., Zeman K.L., Brown J.S., Kim C., Heyder J., and Stahlhofen W. Bronchial airway deposition and retention of particles in inhaled boluses: effect of anatomic dead space. J. Appl. Physiol. 85 (1998) 685-694
3. Chatburn R.L., and McPeck M. A new system for understanding nebulizer performance. Respir. Care 52 (2007) 1037-1050
4. Clark A.R., Chambers C.B., Muir D., Newhouse M.T., Paboojian S., and Schuler C. The effect of biphasic inhalation profiles on the deposition and clearance of coarse bolus aerosols. J. Aerosol. Med. 20 (2007) 75-82
5. Coates A.L., Allen P.D., MacNeish C.F., Ho S.L., and Lands L.C. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest 119 (2001) 1123-1130
6. Coates A.L., MacNeish C.F., Lands L.C., Meisner D., Kelemen S., and Vadas E.B. A comparison of the availability of tobramycin for inhalation from vented vs. unvented nebulizers. Chest 113 (1998) 951-956
7. Coates A.L., Tipples G., Leung K., Gray M., and Louca E. How many infective viral particles are necessary for successful mass measles immunization by aerosol?. Vaccine 6 (2006) 1578-1585
8. Darquenne C., Brand P., Heyder J., and Paiva M. Aerosol dispersion in human lung: comparison between numerical simulations and experiments for bolus tests. J. Appl. Physiol. 83 (1997) 966-974
9. Fleming J.S., Epps B.P., Conway J.H., and Martonen T.B. Comparison of SPECT aerosol deposition data with a human respiratory tract model. J. Aerosol Med. 19 (2006) 268-278
10. Freijer, J.I., Cassee, F.R., Subramaniam, R., Asghararian, B., Anjilvel, S., Miller, F.J., Bree van, L., Rombout, P.J.A. 1999. Multiple Path Particle Deposition Model (MPPDep Version 1.11). A model for human and rat airway particle deposition. RIVM Report 650010019. National Institute for Public Health and the Environement (RIVM). Chemical Industry Institute of Toxicology (CIIT). Bithoven, The Netherlands.
11. Gebhart J., Heicwer G., Heyder J., Roth C., and Stahlhofen W. The use of light scattering photometry in aerosol medicine. J. Aerosol Med. 2 (1988) 89-112
12. Ho S.L., Kwong W.T., O'Drowsky L., and Coates A.L. Evaluation of four breath-enhanced nebulizers for home use. J. Aerosol Med. 14 (2001) 467-475
13. ICRP (International Commission for Radiological Protection), 1994. ICRP Publication 66. Human Respiratory Tract Model for Radiological Protection. Pergamon Press, Oxford, UK.
14. Jarvis, N.S., Birchall, A., James, A.C., Bailey, M.R., Dorrian, M.-F., 1996. LUDEP 2.0 Personal Computer Program for Calculating Internal Doses Using the ICRP Publication 66 Respiratory tract Model. National Radiological Protection Board, Chilton, UK.
15. Katz S.L., Ho S.L., and Coates A.L. Nebulizer choice for inhaled colistin treatment in cystic fibrosis. Chest 119 (2001) 250-255
16. Leung K., Louca E., and Coates A.L. Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency. Chest 126 (2004) 1619-1627
17. Leung K., Louca E., Munson K., Dutzar B., Anklesaria P., and Coates A.L. Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies. J. Gene Med. 9 (2007) 10-21
18. Kim C.S., Hu S.C., DeWitt P., and Gerrity T.R. Assessment of regional deposition of inhaled particles in human lungs by serial bolus delivery method. J. Appl. Physiol. 81 (1996) 2203-2213
19. Kim C.S., and Hu S.C. Total respiratory tract deposition of fine micrometer-sized particles in healthy adults: empirical equations for sex and breathing pattern. J. Appl. Physiol. 101 (2006) 401-412
20. Vecellio L. The mesh nebulizer, a recent technical innovation for aerosol delivery. Breathe 2 (2006) 252-260
21. Vecellio None L., Grimbert D., Becquemin M.H., Boissinot E., Le Pape A., Lemarie E., and Diot P. Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard. J. Aerosol Med. 14 (2001) 107-114